The effect of cisplatin dose administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.

被引：2
|
作者：
Loong, H. H. F.
Ma, B.
Mo, F.
Leung, S. F.
Hui, E. P.
Kam, M. K.
Chan, S. L.
Chan, A. T. C.
机构：
[1] Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Clin Oncol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab Oncol South China, Shatin, Hong Kong, Peoples R China
[4] CUHK, Sir YK Pao Ctr Canc, Hong Kong Canc Inst, Shatin, Hong Kong, Peoples R China
[5] CUHK, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.5532
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5532
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Weekly cisplatin administration concurrent with radiation therapy for locoregionally advanced nasopharyngeal carcinoma
    Isobe K.
    Uno T.
    Aruga T.
    Kawakami H.
    Ueno N.
    Hanazawa T.
    Okamoto Y.
    Ito H.
    International Journal of Clinical Oncology, 2005, 10 (3) : 201 - 203
  • [22] Phase II trial of concurrent chemoradiotherapy with S-1 versus weekly cisplatin for locoregionally advanced nasopharyngeal carcinoma
    Wen, Linchun
    You, Chuanwen
    Lu, Xiyan
    Zhang, Longzhen
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (03) : 687 - 691
  • [23] Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone
    Chen, Yu-Pei
    Zhang, Wen-Na
    Tang, Ling-Long
    Mao, Yan-Ping
    Liu, Xu
    Chen, Lei
    Zhou, Guan-Qun
    Mai, Hai-Qiang
    Shao, Jian-Yong
    Jia, Wei-Hua
    Kang, Tie-Bang
    Zeng, Mu-Sheng
    Sun, Ying
    Ma, Jun
    BMC CANCER, 2015, 15
  • [24] The effect of induction chemotherapy on tumor volume changes in patients with locoregionally advanced nasopharyngeal carcinoma.
    Han, Guang
    Li, Ying
    Wu, Yuan
    Bi, Jianping
    Li, Yanping
    Zheng, Dandan
    Xie, Conghua
    Hu, Desheng
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [25] Loading-dose ibandronate improves opioid-resistant headache in locoregionally advanced nasopharyngeal carcinoma patients prior to concurrent chemoradiotherapy
    Chen, Bingguang
    Huang, Hanwen
    Cai, Bang
    Zhao, Peng
    Su, Jiaxing
    Yan, Mingji
    Wen, Ge
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (07): : 5092 - 5099
  • [26] Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone
    Yu-Pei Chen
    Wen-Na Zhang
    Ling-Long Tang
    Yan-Ping Mao
    Xu Liu
    Lei Chen
    Guan-Qun Zhou
    Hai-Qiang Mai
    Jian-Yong Shao
    Wei-Hua Jia
    Tie-Bang Kang
    Mu-Sheng Zeng
    Ying Sun
    Jun Ma
    BMC Cancer, 15
  • [27] Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis
    Liao, Jun-Fang
    Zhang, Qun
    Du, Xiao-Jing
    Lan, Mei
    Liu, Shan
    Xia, Yun-Fei
    Cai, Xiu-Yu
    Luo, Wei
    CANCER COMMUNICATIONS, 2019, 39
  • [28] Effect of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy on Nutritional Status in Locoregionally Advanced Nasopharyngeal Carcinoma Patients: A Prospective Observational Study
    Miao, J.
    Hu, C.
    Lin, S.
    Chen, X.
    Chen, Y.
    Zhong, Y.
    Jin, F.
    Lin, Q.
    Hu, X.
    Zhang, N.
    Wang, R.
    Wang, L.
    Wang, C.
    Zhu, M.
    Wu, H.
    Di, M.
    Huang, Y.
    Xie, C.
    Zhao, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E334 - E334
  • [29] Clinical value of docetaxel plus cisplatin (TP) induction chemotherapy followed by TP concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma
    Tao, Hao-Yun
    Zhan, Ze-Jiang
    Qiu, Wen-Ze
    Liao, Kai
    Yuan, Ya-Wei
    Yuan, Tai-Ze
    Zheng, Rong-Hui
    JOURNAL OF CANCER, 2021, 12 (01): : 18 - 27
  • [30] TIRA study: A phase III, multicenter, randomized controlled study of toripalimab plus radical chemoradiotherapy with or without concurrent cisplatin in patients with high-risk locoregionally advanced nasopharyngeal carcinoma.
    Xu, Cheng
    Ma, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345